JP2015502915A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502915A5 JP2015502915A5 JP2014534890A JP2014534890A JP2015502915A5 JP 2015502915 A5 JP2015502915 A5 JP 2015502915A5 JP 2014534890 A JP2014534890 A JP 2014534890A JP 2014534890 A JP2014534890 A JP 2014534890A JP 2015502915 A5 JP2015502915 A5 JP 2015502915A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- antigen
- binding portion
- isolated antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161547307P | 2011-10-14 | 2011-10-14 | |
| AU2011904190A AU2011904190A0 (en) | 2011-10-14 | Antibodies to CD1d | |
| AU2011904190 | 2011-10-14 | ||
| US61/547,307 | 2011-10-14 | ||
| PCT/AU2012/001247 WO2013053021A1 (en) | 2011-10-14 | 2012-10-15 | ANTIBODIES TO CD1d |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502915A JP2015502915A (ja) | 2015-01-29 |
| JP2015502915A5 true JP2015502915A5 (enExample) | 2015-12-03 |
Family
ID=48081279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534890A Pending JP2015502915A (ja) | 2011-10-14 | 2012-10-15 | ＣＤ１ｄに対する抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20140286957A1 (enExample) |
| EP (1) | EP2766042A4 (enExample) |
| JP (1) | JP2015502915A (enExample) |
| KR (1) | KR20140108520A (enExample) |
| CN (1) | CN104144700B (enExample) |
| AU (1) | AU2012323781B8 (enExample) |
| BR (1) | BR112014008691A2 (enExample) |
| CA (1) | CA2850961A1 (enExample) |
| EA (1) | EA201400447A1 (enExample) |
| IL (1) | IL231975A0 (enExample) |
| MX (1) | MX2014004326A (enExample) |
| SG (1) | SG11201400521PA (enExample) |
| WO (1) | WO2013053021A1 (enExample) |
| ZA (1) | ZA201401776B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX386714B (es) * | 2015-01-27 | 2025-03-11 | Lava Therapeutics N V | Anticuerpos de dominio simple dirigidos al grupo de diferenciación 1d (cd1d). |
| IL308831A (en) * | 2016-04-08 | 2024-01-01 | Immunocore Ltd | T cell receptors |
| KR20190065189A (ko) * | 2016-04-08 | 2019-06-11 | 어댑티뮨 리미티드 | T 세포 수용체 |
| MX395611B (es) * | 2016-04-08 | 2025-03-25 | Adaptimmune Ltd | Receptores de celulas t. |
| CN108079292A (zh) * | 2016-11-23 | 2018-05-29 | 苏州盛迪亚生物医药有限公司 | 一种抗pd-1抗体在制备治疗肝癌的药物中的用途 |
| CN118662615A (zh) * | 2017-03-15 | 2024-09-20 | 浩康生物系统公司 | 用于造血干细胞移植的组合物和方法 |
| JP7457007B2 (ja) | 2018-09-19 | 2024-03-27 | ラヴァ・セラピューティクス・エヌ・ヴイ | 二重作用ＣＤ１ｄ免疫グロブリン |
| GB201820006D0 (en) * | 2018-12-07 | 2019-01-23 | Lifearc | Humanised anti-IL17BR antibody |
| AU2021328375A1 (en) * | 2020-08-18 | 2023-04-13 | Cephalon Llc | Anti-PAR-2 antibodies and methods of use thereof |
| US20240050569A1 (en) * | 2020-12-18 | 2024-02-15 | Bioardis, Llc | Mesothelin binding molecules and uses thereof |
| WO2024038165A1 (en) | 2022-08-18 | 2024-02-22 | Immunocore Ltd | T cell receptor fusion proteins specific for mage a4 |
| CN116217704B (zh) * | 2022-10-25 | 2025-08-15 | 南京医科大学 | 一种抑制肝细胞凋亡的表面分子及其应用 |
| KR20250128342A (ko) * | 2022-12-21 | 2025-08-27 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 입양 면역요법을 위한 향상된 기능을 갖는 cd3 및 itcr을 발현하는 조작된 자연살해세포 |
| WO2024226794A1 (en) * | 2023-04-26 | 2024-10-31 | The Trustees Of Indiana University | Composition and methods for treatment of spinal cord injury and traumatic brain injury |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003524146A (ja) * | 1998-07-09 | 2003-08-12 | ニッコロフ，ブライアン・ジェイ | Ｔ細胞上のナチュラルキラーレセプターとそれらに対応するリガンドとの相互作用を変調することにより疾患を治療する方法 |
| WO2003092615A2 (en) * | 2002-05-01 | 2003-11-13 | Beth Israel Deaconess Medical Center | Use of anti-cd1 antibodies for the modulation of immune responses |
| WO2008100912A1 (en) * | 2007-02-12 | 2008-08-21 | The General Hospital Corporation | Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| US8012484B2 (en) * | 2007-04-12 | 2011-09-06 | University Of Virginia Patent Foundation | Method of treating ischemia reperfusion injury by inhibiting NKT cell activity |
-
2012
- 2012-10-15 SG SG11201400521PA patent/SG11201400521PA/en unknown
- 2012-10-15 EA EA201400447A patent/EA201400447A1/ru unknown
- 2012-10-15 CA CA2850961A patent/CA2850961A1/en not_active Abandoned
- 2012-10-15 WO PCT/AU2012/001247 patent/WO2013053021A1/en not_active Ceased
- 2012-10-15 MX MX2014004326A patent/MX2014004326A/es unknown
- 2012-10-15 CN CN201280050432.2A patent/CN104144700B/zh not_active Expired - Fee Related
- 2012-10-15 AU AU2012323781A patent/AU2012323781B8/en not_active Ceased
- 2012-10-15 BR BR112014008691A patent/BR112014008691A2/pt unknown
- 2012-10-15 EP EP12840164.3A patent/EP2766042A4/en not_active Withdrawn
- 2012-10-15 JP JP2014534890A patent/JP2015502915A/ja active Pending
- 2012-10-15 KR KR1020147012848A patent/KR20140108520A/ko not_active Withdrawn
-
2014
- 2014-03-11 ZA ZA2014/01776A patent/ZA201401776B/en unknown
- 2014-04-07 IL IL231975A patent/IL231975A0/en unknown
- 2014-04-10 US US14/249,566 patent/US20140286957A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009533020A5 (enExample) | ||
| JP2012525829A5 (enExample) | ||
| RU2017137872A (ru) | Композиции для ингибирования masp-2-зависимой активации комплемента | |
| HRP20150623T1 (hr) | Monoklonalno protutijelo sposobno za vezivanje na specifiäśni diskontinuirani epitop koji se pojavljuje u podruäśju ad1 od humanog glikoproteina citomegalovirusa gb, te njegov fragment koji se veže na antigen | |
| RU2017128882A (ru) | Антитела к биотину и способы их применения | |
| JP2012502649A5 (enExample) | ||
| JP2014534242A5 (enExample) | ||
| NO20074867L (no) | Antistoffer mot CCR5 og anvendelser derav | |
| JP2015504306A5 (enExample) | ||
| JP2011173884A5 (enExample) | ||
| JP2012500020A5 (enExample) | ||
| HRP20191219T1 (hr) | Molekule protutijela koje imaju specifičnost za ljudski ox40 | |
| JP2013502204A5 (enExample) | ||
| JP2020504101A5 (enExample) | ||
| JP2012530496A5 (enExample) | ||
| JP2012511329A5 (enExample) | ||
| HRP20180269T1 (hr) | Anti-cd40 protutijela, upotrebe i postupci | |
| RU2020129387A (ru) | Антитела к pd-1 собак | |
| IL265434B2 (en) | Anti-cd27 antibodies | |
| JP2011519571A5 (enExample) | ||
| AU2016204274A1 (en) | Antibodies that bind to OX40 and their uses | |
| HRP20131167T1 (hr) | Antitijela za humani receptor programirane smrti pd-1 | |
| JP2013198490A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| FI3322727T3 (fi) | Humanisoituja tai kimeerisiä CD3-vasta-aineita |